ReviewCurrent oncology (Toronto, Ont.)2026

Evolution of the Use of Circulating DNA as a Biomarker in Neoadjuvant Therapy of Breast Cancer.

Jannis Tornikidis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.